Rock Immune, Inc.
Immunotoxins for Cancer Therapy
Denver, United States · Founded 2023
- Headquarters
- Denver, Colorado
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2G
- Website
- rockimmune.com
About
Rock Immune is an early-stage biopharmaceutical company focused on the development and commercialization of diphtheria toxin-based recombinant immunotoxins for the treatment of cancer and autoimmune diseases. Their lead drug candidate, Rock425 (CCR4-IL2 IT), targets cutaneous T-cell lymphoma and is supported by a $2.4M NCI STTR Fast Track grant. The company was founded by Dr. Zhirui Wang, who brings 20+ years of expertise in diphtheria toxin-based immunotoxins.
Summary
Rock Immune, Inc. is a Biotech company based in Denver, United States, founded in 2023.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/rock-immune-inc"><img src="https://indexed.vc/api/badge/company/rock-immune-inc" alt="Rock Immune, Inc. on Indexed.vc" width="260" height="76" /></a>